tiprankstipranks
Trending News
More News >
908 Devices Inc. (MASS)
:MASS
US Market
Advertisement

908 Devices (MASS) Stock Forecast & Price Target

Compare
361 Followers
See the Price Targets and Ratings of:

MASS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
908
Devices
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MASS Stock 12 Month Forecast

There Are No Analyst Ratings for MASS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MASS Financial Forecast

MASS Earnings Forecast

Next quarter’s earnings estimate for MASS is -$0.14 with a range of -$0.20 to -$0.10. The previous quarter’s EPS was -$0.36. MASS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MASS has Preformed in-line its overall industry.
Next quarter’s earnings estimate for MASS is -$0.14 with a range of -$0.20 to -$0.10. The previous quarter’s EPS was -$0.36. MASS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MASS has Preformed in-line its overall industry.

MASS Sales Forecast

Next quarter’s sales forecast for MASS is $13.57M with a range of $13.20M to $14.00M. The previous quarter’s sales results were $13.04M. MASS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MASS has Preformed in-line its overall industry.
Next quarter’s sales forecast for MASS is $13.57M with a range of $13.20M to $14.00M. The previous quarter’s sales results were $13.04M. MASS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MASS has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on MASS
TR | OpenAI - 4o
TR | OpenAI - 4o
$7.5$9
Hold
5.14%
Upside
Reiterated
09/26/25
AI Generated ArticleAI Generated Article
Leerink Partners Analyst forecast on MASS
Leerink Partners
Leerink Partners
$7$12
Buy
40.19%
Upside
Upgraded
08/06/25
908 Devices upgraded to Outperform from Market Perform at Leerink908 Devices upgraded to Outperform from Market Perform at Leerink
TD Cowen
Buy
Reiterated
08/05/25
William Blair Analyst forecast on MASS
William Blair
William Blair
Buy
Reiterated
08/05/25
908 Devices (MASS) Receives a Buy from William Blair
Stifel Nicolaus Analyst forecast on MASS
Stifel Nicolaus
Stifel Nicolaus
$6
Buy
-29.91%
Downside
Reiterated
05/22/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), 908 Devices (NASDAQ: MASS) and Supernus Pharmaceuticals (NASDAQ: SUPN)
Stephens
$6
Buy
-29.91%
Downside
Reiterated
01/15/25
Stephens reiterates Overweight Rating on 908 Devices Inc. (MASS)Stephens analyst Jacob Johnson reiterated an Overweight rating and $6.00 price target on 908 Devices Inc. (NASDAQ: MASS).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on MASS
TR | OpenAI - 4o
TR | OpenAI - 4o
$7.5$9
Hold
5.14%
Upside
Reiterated
09/26/25
AI Generated ArticleAI Generated Article
Leerink Partners Analyst forecast on MASS
Leerink Partners
Leerink Partners
$7$12
Buy
40.19%
Upside
Upgraded
08/06/25
908 Devices upgraded to Outperform from Market Perform at Leerink908 Devices upgraded to Outperform from Market Perform at Leerink
TD Cowen
Buy
Reiterated
08/05/25
William Blair Analyst forecast on MASS
William Blair
William Blair
Buy
Reiterated
08/05/25
908 Devices (MASS) Receives a Buy from William Blair
Stifel Nicolaus Analyst forecast on MASS
Stifel Nicolaus
Stifel Nicolaus
$6
Buy
-29.91%
Downside
Reiterated
05/22/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), 908 Devices (NASDAQ: MASS) and Supernus Pharmaceuticals (NASDAQ: SUPN)
Stephens
$6
Buy
-29.91%
Downside
Reiterated
01/15/25
Stephens reiterates Overweight Rating on 908 Devices Inc. (MASS)Stephens analyst Jacob Johnson reiterated an Overweight rating and $6.00 price target on 908 Devices Inc. (NASDAQ: MASS).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering 908 Devices

1 Month
xxx
Success Rate
8/12 ratings generated profit
67%
Average Return
+9.01%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +9.01% per trade.
3 Months
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+15.46%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +15.46% per trade.
1 Year
Daniel AriasStifel Nicolaus
Success Rate
4/12 ratings generated profit
33%
Average Return
+10.52%
reiterated a buy rating 6 months ago
Copying Daniel Arias's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +10.52% per trade.
2 Years
xxx
Success Rate
5/12 ratings generated profit
42%
Average Return
+2.34%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of +2.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MASS Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
1
0
0
1
1
Buy
12
7
6
3
3
Hold
9
9
12
13
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
16
18
17
17
In the current month, MASS has received 4 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. MASS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MASS Stock Forecast FAQ

What is MASS’s average 12-month price target, according to analysts?
Currently, no data Available
What is MASS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MASS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MASS a Buy, Sell or Hold?
      Currently, no data Available
      What is 908 Devices Inc.’s price target?
      Currently, no data Available
      What do analysts say about 908 Devices Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MASS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis